Table 1 Correlations between P2X7 protein and the main clinico-pathological characteristics of the NSCLC patients
From: P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC)
Characteristic | P2X7 protein expression (%) | p | |
|---|---|---|---|
Low | High | ||
Age | |||
≤68 years | 26 (50) | 26 (50) | 0.74 |
>68 years | 24(53.3) | 21(46.7) | |
Gender | |||
Males | 38(50.7) | 37(49.3) | 0.74 |
Females | 12(54.5) | 10(45.5) | |
Histology | |||
ADC | 27 (54) | 23 (46) | 0.88 |
SCC | 22 (48.9) | 23(51.1) | |
LCC | 1 (50) | 1 (50) | |
Tumor stage | |||
T1 (T1a-T1b) | 4 (33.3) | 8 (66.7) | 0.08 |
T2 (T2a-T2b) | 26(57.8) | 19(42.2) | |
T3 | 11(64.7) | 6 (35.3) | |
T4 | 1 (16.7) | 5 (83.3) | |
Lymph-node status | |||
Negative | 11 (42.3) | 15 (57.7) | 0.08 |
Positive | 31 (63.3) | 18 (36.7) | |
Nx | 0 (0) | 5 (100) | |